-transparent.png){kind=logo}
Six postmenopausal women were treated at two ocasions with an oral dose of, respectively, 2 mg and 6 mg oestriol per day for 14 days; at least one month interval separated the two treatment periods. Blood was collected for prolactin measurement (homologous human radioimmunoassay) every other day during each treatment period as well as during a 14 days control period in the same subjects. Mean prolactin level during oestriol administration, regardless of the dose, was statistically not significantly different from that observed during the control period.
Related Publications
M Badawi, and
M L'Hermite, and
C Robyn
February 1977,
Ceskoslovenska gynekologie,
M Badawi, and
M L'Hermite, and
C Robyn
June 1979,
Maturitas,
M Badawi, and
M L'Hermite, and
C Robyn
January 1977,
Annales chirurgiae et gynaecologiae,
M Badawi, and
M L'Hermite, and
C Robyn
January 1981,
Annales d'endocrinologie,
M Badawi, and
M L'Hermite, and
C Robyn
August 1981,
Ceskoslovenska gynekologie,
M Badawi, and
M L'Hermite, and
C Robyn
November 1976,
Wiener klinische Wochenschrift,
M Badawi, and
M L'Hermite, and
C Robyn
April 1976,
Geburtshilfe und Frauenheilkunde,
M Badawi, and
M L'Hermite, and
C Robyn
April 1973,
Arzneimittel-Forschung,
M Badawi, and
M L'Hermite, and
C Robyn
January 1975,
Archiv fur Gynakologie,
M Badawi, and
M L'Hermite, and
C Robyn
January 1979,
Zentralblatt fur Gynakologie,
